{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:15:00Z","timestamp":1791245700554,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The clinical epidemiology of treated HIV infection in the United States has dramatically changed in the past 25 years. Few sources of longitudinal data exist for people with HIV (PWH) spanning that period. Cohort data enable investigating new exposure and disease associations and monitoring progress along the HIV care continuum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We synthesized key published findings and conducted primary data analyses in the HIV Outpatient Study (HOPS), an open cohort of PWH seen at public and private HIV clinics since 1993. We assessed temporal trends in health outcomes (1993\u20132017) and mortality (1994\u20132017) for 10 566 HOPS participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The HOPS contributed to characterizing new conditions (eg, lipodystrophy), demonstrated reduced mortality with earlier HIV treatment, uncovered associations between select antiretroviral agents and cardiovascular disease, and documented remarkable shifts in morbidity from AIDS opportunistic infections to chronic noncommunicable diseases. The median CD4 cell count of participants increased from 244 cells\/mm3 to 640 cells\/mm3 from 1993 to 2017. Mortality fell from 121 to 16 per 1000 person-years from 1994 to 2017 (P\u2005&amp;lt;\u2005.001). In 2010, 83.7% of HOPS participants had a most recent HIV viral load &amp;lt;200 copies\/mL, compared with 92.2% in 2017.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Since 1993, the HOPS has been detecting emerging issues and challenges in HIV disease management. HOPS data can also be used for monitoring trends in infectious and chronic diseases, immunologic and viral suppression status, retention in care, and survival, thereby informing progress toward the Ending the HIV Epidemic initiative.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa123","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T21:45:29Z","timestamp":1586641529000},"source":"Crossref","is-referenced-by-count":25,"title":["The HIV Outpatient Study\u201425 Years of HIV Patient Care and Epidemiologic Research"],"prefix":"10.1093","volume":"7","author":[{"given":"Kate","family":"Buchacz","sequence":"first","affiliation":[{"name":"Division of HIV\/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Armon","sequence":"first","affiliation":[{"name":"Cerner Corporation, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frank J","family":"Palella","sequence":"first","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Novak","sequence":"first","affiliation":[{"name":"University of Illinois College of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Fuhrer","sequence":"first","affiliation":[{"name":"Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Tedaldi","sequence":"first","affiliation":[{"name":"Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Ward","sequence":"first","affiliation":[{"name":"Dupont Circle Physicians Group, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Mayer","sequence":"first","affiliation":[{"name":"St. Joseph\u2019s Hospital Comprehensive Research Institute, Tampa Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Battalora","sequence":"first","affiliation":[{"name":"Cerner Corporation, Kansas City, Missouri, USA"},{"name":"Colorado School of Mines, Golden, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Carlson","sequence":"first","affiliation":[{"name":"Cerner Corporation, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Purinton","sequence":"first","affiliation":[{"name":"Cerner Corporation, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Durham","sequence":"first","affiliation":[{"name":"Division of HIV\/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"first","affiliation":[{"name":"Division of HIV\/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the HIV Outpatient Study (HOPS) Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Buchacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus D","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Akridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Purinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Rayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selom","family":"Agbobil-Nuwoaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliope","family":"Chagaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Armon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Battalora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cerner","family":"Corporation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kansas","family":"City","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Palella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor Daniel","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Widick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Fuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ording-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stony","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Tedaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona A","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Ruley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Beadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princess","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wendrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stockton","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loraine","family":"VanSlyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Beitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Maroney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"key":"2020051903081318800_CIT0001","author":"Centers for Disease Control and Prevention"},{"key":"2020051903081318800_CIT0002","author":"Department of Health and Human Services."},{"issue":"9","key":"2020051903081318800_CIT0003","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"2020051903081318800_CIT0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cit665","article-title":"Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Aberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0005","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMp1904113","article-title":"AIDS in America - back in the headlines at long last","volume":"380","author":"El-Sadr","year":"2019","journal-title":"N Engl J Med"},{"key":"2020051903081318800_CIT0006","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(17)31917-7","article-title":"Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial","volume":"390","author":"Margolis","year":"2017","journal-title":"Lancet"},{"key":"2020051903081318800_CIT0007","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/civ438","article-title":"HIV coinfected have similar SVR rates as HCV monoinfected with DAAs: it\u2019s time to end segregation and integrate HIV patients into HCV trials","volume":"61","author":"Shafran","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0008","first-page":"869841","article-title":"CD4 cell counts at HIV diagnosis among HIV outpatient study participants, 2000-2009","volume":"2012","author":"Buchacz","year":"2012","journal-title":"AIDS Res Treat"},{"key":"2020051903081318800_CIT0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0000000000000813","article-title":"Antiretroviral regimen durability and success in treatment-naive and treatment-experienced patients by year of treatment initiation, United States, 1996\u20132011","volume":"71","author":"Sheth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0010","author":"Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents."},{"key":"2020051903081318800_CIT0011","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"2020051903081318800_CIT0012","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/00002030-200207050-00009","article-title":"Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count &gt; 350 x 10(6) \/l","volume":"16","author":"Opravil","year":"2002","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0013","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy","volume":"286","author":"Hogg","year":"2001","journal-title":"JAMA"},{"key":"2020051903081318800_CIT0014","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-138-8-200304150-00007","article-title":"Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata","volume":"138","author":"Palella","year":"2003","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0017","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0018","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0b013e3283511e91","article-title":"Immune reconstitution inflammatory syndrome: incidence and implications for mortality","volume":"26","author":"Novak","year":"2012","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0019","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000\u20132006","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3851\/IMP2979","article-title":"Low bone mineral density and risk of incident fracture in HIV-infected adults","volume":"21","author":"Battalora","year":"2016","journal-title":"Antivir Ther"},{"key":"2020051903081318800_CIT0021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1874613601509010123","article-title":"A matter of perspective: comparison of the characteristics of persons with HIV infection in the United States from the HIV outpatient study, medical monitoring project, and national HIV surveillance system","volume":"9","author":"Buchacz","year":"2015","journal-title":"Open AIDS J"},{"key":"2020051903081318800_CIT0022","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2017.0162","article-title":"Disparities in HIV viral load suppression by race\/ethnicity among men who have sex with men in the HIV Outpatient Study","author":"Buchacz","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2020051903081318800_CIT0023","doi-asserted-by":"crossref","first-page":"e0189973","DOI":"10.1371\/journal.pone.0189973","article-title":"Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010\u20132015","volume":"13","author":"Geter","year":"2018","journal-title":"PLoS One"},{"key":"2020051903081318800_CIT0024","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200210180-00008","article-title":"Prevalence and clinical correlates of HIV viremia (\u2018blips\u2019) in patients with previous suppression below the limits of quantification","volume":"16","author":"Sklar","year":"2002","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/2325957415600799","article-title":"HIV viral load monitoring frequency and risk of treatment failure among immunologically stable HIV-infected patients prescribed combination antiretroviral therapy","volume":"14","author":"Young","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2020051903081318800_CIT0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0b013e328304b38b","article-title":"Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994\u20132005","volume":"22","author":"Buchacz","year":"2008","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3851\/IMP2450","article-title":"Disparities in prevalence of key chronic diseases by gender and race\/ethnicity among antiretroviral-treated HIV-infected adults in the US","volume":"18","author":"Buchacz","year":"2013","journal-title":"Antivir Ther"},{"key":"2020051903081318800_CIT0029","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2893.2009.01249.x","article-title":"Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996\u20132007","volume":"17","author":"Spradling","year":"2010","journal-title":"J Viral Hepat"},{"key":"2020051903081318800_CIT0031","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/QAI.0b013e3181b67527","article-title":"Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996\u20132007","volume":"53","author":"Spradling","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0032","doi-asserted-by":"crossref","first-page":"ofx076","DOI":"10.1093\/ofid\/ofx076","article-title":"Incidence of hepatitis C virus infection in the Human Immunodeficiency Virus Outpatient Study cohort, 2000\u20132013","volume":"4","author":"Samandari","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020051903081318800_CIT0033","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/cid\/ciy348","article-title":"Risk factors and incidence of syphilis in human immunodeficiency virus (HIV)-infected persons: the HIV Outpatient Study, 1999\u20132015","volume":"67","author":"Novak","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0034","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e31817af461","article-title":"Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women\u2019s Interagency HIV Study","volume":"48","author":"Sobieszczyk","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1086\/523577","article-title":"Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?","volume":"45","author":"Goulet","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0036","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/QAD.0b013e3282e9a664","article-title":"Trends in perimortal conditions and mortality rates among HIV-infected patients","volume":"21","author":"Hooshyar","year":"2007","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0037","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"2020051903081318800_CIT0038","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1047-2797(99)00005-8","article-title":"Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV Outpatient Study (HOPS)","volume":"9","author":"Moorman","year":"1999","journal-title":"Ann Epidemiol"},{"key":"2020051903081318800_CIT0039","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"2020051903081318800_CIT0040","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0041","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-129-2-199807150-00032","article-title":"\u201cBuffalo humps\u201d associated with protease inhibitors","volume":"129","author":"Schindler","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0042","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/428840","article-title":"Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment","volume":"40","author":"Gallant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0043","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200404300-00019","article-title":"Renal safety of tenofovir in HIV treatment-experienced patients","volume":"18","author":"Izzedine","year":"2004","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0044","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1545109707300676","article-title":"Renal function in tenofovir-exposed and tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study","volume":"6","author":"Young","year":"2007","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"2020051903081318800_CIT0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/apc.2008.0232","article-title":"Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study","volume":"23","author":"Young","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"2020051903081318800_CIT0046","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-151-2-200907210-00003","article-title":"The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study","volume":"151","author":"Palella","year":"2009","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0047","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/cid\/ciw615","article-title":"Cardiovascular disease risk prediction in the HIV Outpatient Study","volume":"63","author":"Thompson-Paul","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0048","doi-asserted-by":"crossref","article-title":"New fracture risk and FRAX 10-year probability of fracture in HIV-infected adults.","author":"Battalora","DOI":"10.1016\/j.jval.2014.03.1563"},{"key":"2020051903081318800_CIT0049","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/apc.2013.0270","article-title":"Is primary Mycobacterium avium complex prophylaxis necessary in patients with CD4 &lt;50 cells\/\u03bcL who are virologically suppressed on cART?","volume":"28","author":"Yangco","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"2020051903081318800_CIT0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-132-3-200002010-00005","article-title":"Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators","volume":"132","author":"Yangco","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0051","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/QAI.0b013e31828c20d8","article-title":"Sexual risk behavior and viremia among men who have sex with men in the HIV Outpatient Study, United States, 2007\u20132010","volume":"63","author":"Durham","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0052","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0956462417720547","article-title":"Antiretroviral nonadherence and condomless sex in the HIV Outpatient Study, USA, 2007\u20132014","volume":"29","author":"Durham","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2020051903081318800_CIT0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0000000000000652","article-title":"Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV Outpatient Study, 2000\u20132013","volume":"70","author":"Novak","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020051903081318800_CIT0054","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/QAD.0b013e32834b3537","article-title":"Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment","volume":"25","author":"Palella","year":"2011","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0055","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s11606-013-2449-6","article-title":"Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population","volume":"28","author":"Holtzman","year":"2013","journal-title":"J Gen Intern Med"},{"key":"2020051903081318800_CIT0056","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/2325957413514631","article-title":"Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who\u2019s in and who\u2019s out?","volume":"13","author":"Tedaldi","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2020051903081318800_CIT0057","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1097\/QAD.0000000000002349","article-title":"Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care","volume":"33","author":"Palella","year":"2019","journal-title":"AIDS"},{"key":"2020051903081318800_CIT0058","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-157-5-201209040-00005","article-title":"U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008","volume":"157","author":"Althoff","year":"2012","journal-title":"Ann Intern Med"},{"key":"2020051903081318800_CIT0059","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020051903081318800_CIT0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1179\/1528433614Z.0000000019","article-title":"Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study","volume":"16","author":"Buchacz","year":"2015","journal-title":"HIV Clin Trials"},{"key":"2020051903081318800_CIT0061","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0956462419880127","article-title":"Changes in HIV antiretroviral prescribing practices in the United States","volume":"31","author":"Vu","year":"2020","journal-title":"Int J STD AIDS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa123\/33036169\/ofaa123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/5\/ofaa123\/33236126\/ofaa123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/5\/ofaa123\/33236126\/ofaa123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T07:08:59Z","timestamp":1589872139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa123\/5819208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,11]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa123","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,4,11]]},"article-number":"ofaa123"}}